⌘K

Login Start Free

Home/Filings/4/0001641172-25-013339

4//SEC Filing

Weiler Peter J. 4

Accession 0001641172-25-013339

CIK 0001540159other

View on SEC.gov Company Profile

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 9:00 PM ET

Size

5.0 KB

Accession

0001641172-25-013339

Insider Transaction Report

Form 4

Period: 2025-05-29

Edesa Biotech, Inc.EDSA

Weiler Peter J.

Chief Financial Officer

Transactions

Award
Common Shares
2025-05-29+65,000→ 65,000 total

Footnotes (1)

[F1]Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest monthly in equal proportions over thirty-six (36) months, commencing on the grant date.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Edesa Biotech, Inc.

CIK 0001540159

Entity typeother

Related Parties

1

filerCIK 0002066576

Filing Metadata

Form type: 4
Filed: Jun 1, 8:00 PM ET
Accepted: Jun 2, 9:00 PM ET
Size: 5.0 KB

View on SEC.gov